The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer

Systemic targeted therapy in prostate cancer is primarily focused on ablating androgen signaling. Androgen deprivation therapy and second-generation androgen receptor (AR)–targeted therapy selectively favor the development of treatment-resistant subtypes of metastatic castration-resistant prostate c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lundberg, Arian, Zhang, Meng, Aggarwal, Rahul, Li, Haolong, Zhang, Li, Foye, Adam, Sjöström, Martin, Chou, Jonathan, Chang, Kevin, Moreno-Rodriguez, Thaidy, Shrestha, Raunak, Baskin, Avi, Zhu, Xiaolin, Weinstein, Alana S., Younger, Noah, Alumkal, Joshi J., Beer, Tomasz M., Chi, Kim N., Evans, Christopher P., Gleave, Martin, Lara, Primo N., Reiter, Rob E., Rettig, Matthew B., Witte, Owen N., Wyatt, Alexander W., Feng, Felix Y., Small, Eric J., Quigley, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Cancer Landscapes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425725/
https://www.ncbi.nlm.nih.gov/pubmed/37289025
http://dx.doi.org/10.1158/0008-5472.CAN-23-0593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425725/
https://www.ncbi.nlm.nih.gov/pubmed/37289025
http://dx.doi.org/10.1158/0008-5472.CAN-23-0593

Ejemplares similares